nodes	percent_of_prediction	percent_of_DWPC	metapath
Metformin—NDUFS3—Doxorubicin—lung cancer	0.136	0.289	CbGbCtD
Metformin—NDUFS2—Doxorubicin—lung cancer	0.136	0.289	CbGbCtD
Metformin—NDUFS7—Doxorubicin—lung cancer	0.136	0.289	CbGbCtD
Metformin—SLC22A3—Irinotecan—lung cancer	0.031	0.066	CbGbCtD
Metformin—SLC22A2—Vinblastine—lung cancer	0.0163	0.0347	CbGbCtD
Metformin—SLC22A2—Cisplatin—lung cancer	0.015	0.0318	CbGbCtD
Metformin—NDUFA2—Podofilox—Teniposide—lung cancer	0.000897	0.175	CbGdCrCtD
Metformin—NDUFA6—respiratory system—lung cancer	0.000801	0.00511	CbGeAlD
Metformin—NDUFS4—respiratory system—lung cancer	0.000796	0.00507	CbGeAlD
Metformin—NDUFB4—respiratory system—lung cancer	0.000786	0.00501	CbGeAlD
Metformin—NDUFA4L2—trachea—lung cancer	0.000781	0.00498	CbGeAlD
Metformin—NDUFAB1—respiratory system—lung cancer	0.000781	0.00498	CbGeAlD
Metformin—NDUFB9—respiratory system—lung cancer	0.000776	0.00495	CbGeAlD
Metformin—NDUFA2—bronchus—lung cancer	0.000776	0.00494	CbGeAlD
Metformin—NDUFA4—respiratory system—lung cancer	0.000771	0.00492	CbGeAlD
Metformin—NDUFV1—respiratory system—lung cancer	0.000767	0.00489	CbGeAlD
Metformin—NDUFB11—respiratory system—lung cancer	0.000767	0.00489	CbGeAlD
Metformin—NDUFS5—respiratory system—lung cancer	0.000762	0.00486	CbGeAlD
Metformin—NDUFB8—respiratory system—lung cancer	0.000762	0.00486	CbGeAlD
Metformin—NDUFS6—lung—lung cancer	0.000741	0.00472	CbGeAlD
Metformin—NDUFA10—bronchus—lung cancer	0.00074	0.00472	CbGeAlD
Metformin—NDUFA4L2—cardiac atrium—lung cancer	0.000734	0.00468	CbGeAlD
Metformin—NDUFC1—bronchus—lung cancer	0.000733	0.00468	CbGeAlD
Metformin—NDUFB2—bronchus—lung cancer	0.000727	0.00464	CbGeAlD
Metformin—NDUFS6—Afatinib—Gefitinib—lung cancer	0.000725	0.141	CbGdCrCtD
Metformin—NDUFA7—lung—lung cancer	0.000722	0.0046	CbGeAlD
Metformin—NDUFAF1—bronchus—lung cancer	0.000721	0.0046	CbGeAlD
Metformin—NDUFB3—bronchus—lung cancer	0.000709	0.00452	CbGeAlD
Metformin—NDUFAF2—bronchus—lung cancer	0.000709	0.00452	CbGeAlD
Metformin—NDUFA5—bronchus—lung cancer	0.000693	0.00442	CbGeAlD
Metformin—NDUFA11—bronchus—lung cancer	0.000693	0.00442	CbGeAlD
Metformin—NDUFAF4—bronchus—lung cancer	0.000688	0.00439	CbGeAlD
Metformin—NDUFB6—bronchus—lung cancer	0.000688	0.00439	CbGeAlD
Metformin—NDUFA12—epithelium—lung cancer	0.000684	0.00436	CbGeAlD
Metformin—NDUFS1—bronchus—lung cancer	0.000683	0.00435	CbGeAlD
Metformin—NDUFB10—bronchus—lung cancer	0.000678	0.00432	CbGeAlD
Metformin—NDUFAF3—lung—lung cancer	0.000674	0.0043	CbGeAlD
Metformin—NDUFA12—bronchus—lung cancer	0.000673	0.00429	CbGeAlD
Metformin—NDUFB7—bronchus—lung cancer	0.000673	0.00429	CbGeAlD
Metformin—NDUFB1—bronchus—lung cancer	0.000669	0.00426	CbGeAlD
Metformin—NDUFS8—bronchus—lung cancer	0.000669	0.00426	CbGeAlD
Metformin—NDUFAB1—Afatinib—Gefitinib—lung cancer	0.000663	0.129	CbGdCrCtD
Metformin—NDUFB5—bronchus—lung cancer	0.00066	0.0042	CbGeAlD
Metformin—NDUFA6—bronchus—lung cancer	0.00066	0.0042	CbGeAlD
Metformin—NDUFS4—bronchus—lung cancer	0.000655	0.00418	CbGeAlD
Metformin—NDUFA2—cardiac atrium—lung cancer	0.000654	0.00417	CbGeAlD
Metformin—PRKAB1—respiratory system—lung cancer	0.000653	0.00416	CbGeAlD
Metformin—NDUFAB1—epithelium—lung cancer	0.000653	0.00416	CbGeAlD
Metformin—NDUFB9—epithelium—lung cancer	0.000649	0.00413	CbGeAlD
Metformin—NDUFAF1—trachea—lung cancer	0.000648	0.00413	CbGeAlD
Metformin—NDUFB4—bronchus—lung cancer	0.000647	0.00412	CbGeAlD
Metformin—NDUFAB1—bronchus—lung cancer	0.000643	0.0041	CbGeAlD
Metformin—NDUFB9—bronchus—lung cancer	0.000639	0.00407	CbGeAlD
Metformin—NDUFA8—bronchus—lung cancer	0.000639	0.00407	CbGeAlD
Metformin—NDUFB3—trachea—lung cancer	0.000637	0.00406	CbGeAlD
Metformin—NDUFAF2—trachea—lung cancer	0.000637	0.00406	CbGeAlD
Metformin—NDUFS5—epithelium—lung cancer	0.000637	0.00406	CbGeAlD
Metformin—NDUFA4—bronchus—lung cancer	0.000635	0.00405	CbGeAlD
Metformin—NDUFV1—bronchus—lung cancer	0.000631	0.00402	CbGeAlD
Metformin—NDUFB11—bronchus—lung cancer	0.000631	0.00402	CbGeAlD
Metformin—NDUFB8—bronchus—lung cancer	0.000627	0.004	CbGeAlD
Metformin—NDUFS5—bronchus—lung cancer	0.000627	0.004	CbGeAlD
Metformin—NDUFA5—trachea—lung cancer	0.000622	0.00397	CbGeAlD
Metformin—NDUFA11—trachea—lung cancer	0.000622	0.00397	CbGeAlD
Metformin—NDUFC1—cardiac atrium—lung cancer	0.000619	0.00394	CbGeAlD
Metformin—NDUFAF4—trachea—lung cancer	0.000618	0.00394	CbGeAlD
Metformin—NDUFB6—trachea—lung cancer	0.000618	0.00394	CbGeAlD
Metformin—NDUFA13—Afatinib—Gefitinib—lung cancer	0.000616	0.12	CbGdCrCtD
Metformin—NDUFC2—respiratory system—lung cancer	0.000616	0.00392	CbGeAlD
Metformin—NDUFB10—trachea—lung cancer	0.000609	0.00388	CbGeAlD
Metformin—NDUFAF1—cardiac atrium—lung cancer	0.000608	0.00388	CbGeAlD
Metformin—NDUFA12—trachea—lung cancer	0.000604	0.00385	CbGeAlD
Metformin—NDUFB7—trachea—lung cancer	0.000604	0.00385	CbGeAlD
Metformin—NDUFA13—lung—lung cancer	0.000604	0.00385	CbGeAlD
Metformin—NDUFA9—lung—lung cancer	0.000604	0.00385	CbGeAlD
Metformin—NDUFS8—trachea—lung cancer	0.0006	0.00383	CbGeAlD
Metformin—NDUFB3—cardiac atrium—lung cancer	0.000598	0.00381	CbGeAlD
Metformin—NDUFAF2—cardiac atrium—lung cancer	0.000598	0.00381	CbGeAlD
Metformin—NDUFA1—lung—lung cancer	0.000595	0.00379	CbGeAlD
Metformin—NDUFA6—trachea—lung cancer	0.000592	0.00378	CbGeAlD
Metformin—NDUFB5—trachea—lung cancer	0.000592	0.00378	CbGeAlD
Metformin—NDUFS2—respiratory system—lung cancer	0.000592	0.00377	CbGeAlD
Metformin—NDUFS4—trachea—lung cancer	0.000588	0.00375	CbGeAlD
Metformin—NDUFS7—bronchus—lung cancer	0.000588	0.00375	CbGeAlD
Metformin—NDUFA11—cardiac atrium—lung cancer	0.000585	0.00373	CbGeAlD
Metformin—NDUFS3—respiratory system—lung cancer	0.000585	0.00373	CbGeAlD
Metformin—ND4L—bone marrow—lung cancer	0.000583	0.00371	CbGeAlD
Metformin—ND3—bone marrow—lung cancer	0.000583	0.00371	CbGeAlD
Metformin—ND2—bone marrow—lung cancer	0.000583	0.00371	CbGeAlD
Metformin—ND5—bone marrow—lung cancer	0.000583	0.00371	CbGeAlD
Metformin—NDUFB4—trachea—lung cancer	0.000581	0.0037	CbGeAlD
Metformin—NDUFB6—cardiac atrium—lung cancer	0.00058	0.0037	CbGeAlD
Metformin—NDUFAF4—cardiac atrium—lung cancer	0.00058	0.0037	CbGeAlD
Metformin—NDUFV2—lung—lung cancer	0.000577	0.00368	CbGeAlD
Metformin—NDUFAB1—trachea—lung cancer	0.000577	0.00368	CbGeAlD
Metformin—NDUFS1—cardiac atrium—lung cancer	0.000576	0.00367	CbGeAlD
Metformin—NDUFB9—trachea—lung cancer	0.000574	0.00366	CbGeAlD
Metformin—NDUFA8—trachea—lung cancer	0.000574	0.00366	CbGeAlD
Metformin—NDUFB10—cardiac atrium—lung cancer	0.000572	0.00365	CbGeAlD
Metformin—NDUFA2—Vincristine—Vinorelbine—lung cancer	0.000571	0.112	CbGdCrCtD
Metformin—NDUFA4—trachea—lung cancer	0.00057	0.00363	CbGeAlD
Metformin—NDUFA12—cardiac atrium—lung cancer	0.000568	0.00362	CbGeAlD
Metformin—NDUFB7—cardiac atrium—lung cancer	0.000568	0.00362	CbGeAlD
Metformin—NDUFB11—trachea—lung cancer	0.000567	0.00361	CbGeAlD
Metformin—NDUFV1—trachea—lung cancer	0.000567	0.00361	CbGeAlD
Metformin—NDUFB1—cardiac atrium—lung cancer	0.000564	0.00359	CbGeAlD
Metformin—NDUFS8—cardiac atrium—lung cancer	0.000564	0.00359	CbGeAlD
Metformin—ND4—bone marrow—lung cancer	0.000564	0.00359	CbGeAlD
Metformin—NDUFS5—trachea—lung cancer	0.000563	0.00359	CbGeAlD
Metformin—NDUFB8—trachea—lung cancer	0.000563	0.00359	CbGeAlD
Metformin—NDUFA4L2—lung—lung cancer	0.000561	0.00358	CbGeAlD
Metformin—NDUFB5—cardiac atrium—lung cancer	0.000556	0.00355	CbGeAlD
Metformin—NDUFA6—cardiac atrium—lung cancer	0.000556	0.00355	CbGeAlD
Metformin—NDUFS4—cardiac atrium—lung cancer	0.000553	0.00352	CbGeAlD
Metformin—NDUFA2—bone marrow—lung cancer	0.000552	0.00352	CbGeAlD
Metformin—NDUFB4—cardiac atrium—lung cancer	0.000546	0.00348	CbGeAlD
Metformin—NDUFAB1—cardiac atrium—lung cancer	0.000542	0.00346	CbGeAlD
Metformin—NDUFB9—cardiac atrium—lung cancer	0.000539	0.00343	CbGeAlD
Metformin—NDUFA8—cardiac atrium—lung cancer	0.000539	0.00343	CbGeAlD
Metformin—PRKAB1—bronchus—lung cancer	0.000538	0.00343	CbGeAlD
Metformin—NDUFA4—cardiac atrium—lung cancer	0.000536	0.00341	CbGeAlD
Metformin—NDUFA2—Podofilox—Etoposide—lung cancer	0.000534	0.104	CbGdCrCtD
Metformin—NDUFV1—cardiac atrium—lung cancer	0.000532	0.00339	CbGeAlD
Metformin—NDUFB11—cardiac atrium—lung cancer	0.000532	0.00339	CbGeAlD
Metformin—NDUFS5—cardiac atrium—lung cancer	0.000529	0.00337	CbGeAlD
Metformin—NDUFB8—cardiac atrium—lung cancer	0.000529	0.00337	CbGeAlD
Metformin—ND3—lung—lung cancer	0.000528	0.00337	CbGeAlD
Metformin—ND2—lung—lung cancer	0.000528	0.00337	CbGeAlD
Metformin—ND5—lung—lung cancer	0.000528	0.00337	CbGeAlD
Metformin—ND4L—lung—lung cancer	0.000528	0.00337	CbGeAlD
Metformin—NDUFA10—bone marrow—lung cancer	0.000527	0.00336	CbGeAlD
Metformin—NDUFC1—bone marrow—lung cancer	0.000522	0.00333	CbGeAlD
Metformin—NDUFB2—bone marrow—lung cancer	0.000518	0.0033	CbGeAlD
Metformin—NDUFC2—epithelium—lung cancer	0.000514	0.00328	CbGeAlD
Metformin—NDUFAF1—bone marrow—lung cancer	0.000514	0.00327	CbGeAlD
Metformin—ND4—lung—lung cancer	0.000511	0.00326	CbGeAlD
Metformin—ND6—bone marrow—lung cancer	0.000509	0.00325	CbGeAlD
Metformin—NDUFC2—bronchus—lung cancer	0.000507	0.00323	CbGeAlD
Metformin—NDUFAF2—bone marrow—lung cancer	0.000505	0.00322	CbGeAlD
Metformin—NDUFB3—bone marrow—lung cancer	0.000505	0.00322	CbGeAlD
Metformin—NDUFA2—lung—lung cancer	0.0005	0.00319	CbGeAlD
Metformin—NDUFS7—cardiac atrium—lung cancer	0.000496	0.00316	CbGeAlD
Metformin—NDUFA7—lymph node—lung cancer	0.000494	0.00315	CbGeAlD
Metformin—NDUFA5—bone marrow—lung cancer	0.000494	0.00315	CbGeAlD
Metformin—NDUFAF4—bone marrow—lung cancer	0.00049	0.00312	CbGeAlD
Metformin—NDUFB6—bone marrow—lung cancer	0.00049	0.00312	CbGeAlD
Metformin—NDUFS2—bronchus—lung cancer	0.000487	0.00311	CbGeAlD
Metformin—NDUFS1—bone marrow—lung cancer	0.000486	0.0031	CbGeAlD
Metformin—ND1—respiratory system—lung cancer	0.000486	0.0031	CbGeAlD
Metformin—NDUFB10—bone marrow—lung cancer	0.000483	0.00308	CbGeAlD
Metformin—PRKAB1—trachea—lung cancer	0.000483	0.00308	CbGeAlD
Metformin—NDUFS3—bronchus—lung cancer	0.000481	0.00307	CbGeAlD
Metformin—NDUFA12—bone marrow—lung cancer	0.000479	0.00306	CbGeAlD
Metformin—NDUFB7—bone marrow—lung cancer	0.000479	0.00306	CbGeAlD
Metformin—NDUFA10—lung—lung cancer	0.000477	0.00304	CbGeAlD
Metformin—NDUFS8—bone marrow—lung cancer	0.000476	0.00303	CbGeAlD
Metformin—NDUFB1—bone marrow—lung cancer	0.000476	0.00303	CbGeAlD
Metformin—NDUFC1—lung—lung cancer	0.000473	0.00302	CbGeAlD
Metformin—NDUFB5—bone marrow—lung cancer	0.00047	0.00299	CbGeAlD
Metformin—NDUFA6—bone marrow—lung cancer	0.00047	0.00299	CbGeAlD
Metformin—NDUFB2—lung—lung cancer	0.000469	0.00299	CbGeAlD
Metformin—NDUFS4—bone marrow—lung cancer	0.000467	0.00297	CbGeAlD
Metformin—NDUFAF1—lung—lung cancer	0.000465	0.00297	CbGeAlD
Metformin—ND6—lung—lung cancer	0.000461	0.00294	CbGeAlD
Metformin—NDUFB4—bone marrow—lung cancer	0.000461	0.00294	CbGeAlD
Metformin—NDUFB3—lung—lung cancer	0.000458	0.00292	CbGeAlD
Metformin—NDUFAF2—lung—lung cancer	0.000458	0.00292	CbGeAlD
Metformin—NDUFAB1—bone marrow—lung cancer	0.000458	0.00292	CbGeAlD
Metformin—NDUFA2—Vincristine—Vinblastine—lung cancer	0.000457	0.0891	CbGdCrCtD
Metformin—NDUFC2—trachea—lung cancer	0.000455	0.0029	CbGeAlD
Metformin—NDUFA8—bone marrow—lung cancer	0.000455	0.0029	CbGeAlD
Metformin—NDUFB9—bone marrow—lung cancer	0.000455	0.0029	CbGeAlD
Metformin—NDUFA4—bone marrow—lung cancer	0.000452	0.00288	CbGeAlD
Metformin—NDUFB11—bone marrow—lung cancer	0.000449	0.00286	CbGeAlD
Metformin—NDUFV1—bone marrow—lung cancer	0.000449	0.00286	CbGeAlD
Metformin—NDUFA5—lung—lung cancer	0.000447	0.00285	CbGeAlD
Metformin—NDUFA11—lung—lung cancer	0.000447	0.00285	CbGeAlD
Metformin—NDUFS5—bone marrow—lung cancer	0.000447	0.00285	CbGeAlD
Metformin—NDUFB8—bone marrow—lung cancer	0.000447	0.00285	CbGeAlD
Metformin—NDUFB6—lung—lung cancer	0.000444	0.00283	CbGeAlD
Metformin—NDUFAF4—lung—lung cancer	0.000444	0.00283	CbGeAlD
Metformin—NDUFS1—lung—lung cancer	0.000441	0.00281	CbGeAlD
Metformin—NDUFB10—lung—lung cancer	0.000437	0.00279	CbGeAlD
Metformin—NDUFS2—trachea—lung cancer	0.000437	0.00279	CbGeAlD
Metformin—NDUFB7—lung—lung cancer	0.000434	0.00277	CbGeAlD
Metformin—NDUFA12—lung—lung cancer	0.000434	0.00277	CbGeAlD
Metformin—NDUFS3—trachea—lung cancer	0.000432	0.00275	CbGeAlD
Metformin—NDUFS8—lung—lung cancer	0.000431	0.00275	CbGeAlD
Metformin—NDUFB1—lung—lung cancer	0.000431	0.00275	CbGeAlD
Metformin—NDUFC2—cardiac atrium—lung cancer	0.000427	0.00272	CbGeAlD
Metformin—NDUFB5—lung—lung cancer	0.000426	0.00271	CbGeAlD
Metformin—NDUFA6—lung—lung cancer	0.000426	0.00271	CbGeAlD
Metformin—NDUFS4—lung—lung cancer	0.000423	0.00269	CbGeAlD
Metformin—NDUFS7—bone marrow—lung cancer	0.000419	0.00267	CbGeAlD
Metformin—NDUFB4—lung—lung cancer	0.000417	0.00266	CbGeAlD
Metformin—NDUFAB1—lung—lung cancer	0.000415	0.00264	CbGeAlD
Metformin—NDUFB9—lung—lung cancer	0.000412	0.00263	CbGeAlD
Metformin—NDUFA8—lung—lung cancer	0.000412	0.00263	CbGeAlD
Metformin—NDUFS2—cardiac atrium—lung cancer	0.000411	0.00262	CbGeAlD
Metformin—NDUFA4—lung—lung cancer	0.00041	0.00261	CbGeAlD
Metformin—NDUFB11—lung—lung cancer	0.000407	0.0026	CbGeAlD
Metformin—NDUFV1—lung—lung cancer	0.000407	0.0026	CbGeAlD
Metformin—NDUFS3—cardiac atrium—lung cancer	0.000406	0.00259	CbGeAlD
Metformin—NDUFB8—lung—lung cancer	0.000405	0.00258	CbGeAlD
Metformin—NDUFS5—lung—lung cancer	0.000405	0.00258	CbGeAlD
Metformin—NDUFV2—lymph node—lung cancer	0.000395	0.00252	CbGeAlD
Metformin—NDUFA4L2—lymph node—lung cancer	0.000384	0.00245	CbGeAlD
Metformin—PRKAB1—bone marrow—lung cancer	0.000383	0.00244	CbGeAlD
Metformin—NDUFS7—lung—lung cancer	0.000379	0.00242	CbGeAlD
Metformin—ND4L—lymph node—lung cancer	0.000361	0.0023	CbGeAlD
Metformin—ND3—lymph node—lung cancer	0.000361	0.0023	CbGeAlD
Metformin—ND2—lymph node—lung cancer	0.000361	0.0023	CbGeAlD
Metformin—ND5—lymph node—lung cancer	0.000361	0.0023	CbGeAlD
Metformin—NDUFC2—bone marrow—lung cancer	0.000361	0.0023	CbGeAlD
Metformin—ND4—lymph node—lung cancer	0.000349	0.00223	CbGeAlD
Metformin—PRKAB1—lung—lung cancer	0.000347	0.00221	CbGeAlD
Metformin—NDUFS2—bone marrow—lung cancer	0.000347	0.00221	CbGeAlD
Metformin—NDUFS3—bone marrow—lung cancer	0.000343	0.00218	CbGeAlD
Metformin—NDUFA2—lymph node—lung cancer	0.000342	0.00218	CbGeAlD
Metformin—NDUFC2—lung—lung cancer	0.000327	0.00208	CbGeAlD
Metformin—NDUFA10—lymph node—lung cancer	0.000327	0.00208	CbGeAlD
Metformin—NDUFC1—lymph node—lung cancer	0.000324	0.00206	CbGeAlD
Metformin—NDUFB2—lymph node—lung cancer	0.000321	0.00205	CbGeAlD
Metformin—NDUFAF1—lymph node—lung cancer	0.000318	0.00203	CbGeAlD
Metformin—ND6—lymph node—lung cancer	0.000316	0.00201	CbGeAlD
Metformin—NDUFS2—lung—lung cancer	0.000314	0.002	CbGeAlD
Metformin—NDUFAF2—lymph node—lung cancer	0.000313	0.002	CbGeAlD
Metformin—NDUFB3—lymph node—lung cancer	0.000313	0.002	CbGeAlD
Metformin—NDUFS3—lung—lung cancer	0.00031	0.00198	CbGeAlD
Metformin—NDUFA5—lymph node—lung cancer	0.000306	0.00195	CbGeAlD
Metformin—NDUFA11—lymph node—lung cancer	0.000306	0.00195	CbGeAlD
Metformin—NDUFB6—lymph node—lung cancer	0.000304	0.00194	CbGeAlD
Metformin—NDUFAF4—lymph node—lung cancer	0.000304	0.00194	CbGeAlD
Metformin—NDUFS1—lymph node—lung cancer	0.000301	0.00192	CbGeAlD
Metformin—NDUFB10—lymph node—lung cancer	0.000299	0.00191	CbGeAlD
Metformin—NDUFB7—lymph node—lung cancer	0.000297	0.00189	CbGeAlD
Metformin—NDUFA12—lymph node—lung cancer	0.000297	0.00189	CbGeAlD
Metformin—NDUFS8—lymph node—lung cancer	0.000295	0.00188	CbGeAlD
Metformin—NDUFB1—lymph node—lung cancer	0.000295	0.00188	CbGeAlD
Metformin—NDUFB5—lymph node—lung cancer	0.000291	0.00186	CbGeAlD
Metformin—NDUFA6—lymph node—lung cancer	0.000291	0.00186	CbGeAlD
Metformin—NDUFS4—lymph node—lung cancer	0.000289	0.00184	CbGeAlD
Metformin—NDUFB4—lymph node—lung cancer	0.000285	0.00182	CbGeAlD
Metformin—ND1—bone marrow—lung cancer	0.000285	0.00181	CbGeAlD
Metformin—NDUFAB1—lymph node—lung cancer	0.000284	0.00181	CbGeAlD
Metformin—NDUFA8—lymph node—lung cancer	0.000282	0.0018	CbGeAlD
Metformin—NDUFB9—lymph node—lung cancer	0.000282	0.0018	CbGeAlD
Metformin—NDUFA4—lymph node—lung cancer	0.00028	0.00179	CbGeAlD
Metformin—NDUFB11—lymph node—lung cancer	0.000278	0.00178	CbGeAlD
Metformin—NDUFV1—lymph node—lung cancer	0.000278	0.00178	CbGeAlD
Metformin—NDUFS5—lymph node—lung cancer	0.000277	0.00176	CbGeAlD
Metformin—NDUFB8—lymph node—lung cancer	0.000277	0.00176	CbGeAlD
Metformin—NDUFS7—lymph node—lung cancer	0.000259	0.00165	CbGeAlD
Metformin—ND1—lung—lung cancer	0.000258	0.00164	CbGeAlD
Metformin—NDUFA7—Azacitidine—Gemcitabine—lung cancer	0.000253	0.0494	CbGdCrCtD
Metformin—PRKAB1—lymph node—lung cancer	0.000237	0.00151	CbGeAlD
Metformin—NDUFC2—lymph node—lung cancer	0.000224	0.00143	CbGeAlD
Metformin—NDUFA2—Azacitidine—Gemcitabine—lung cancer	0.000215	0.042	CbGdCrCtD
Metformin—NDUFS2—lymph node—lung cancer	0.000215	0.00137	CbGeAlD
Metformin—NDUFS3—lymph node—lung cancer	0.000212	0.00135	CbGeAlD
Metformin—NDUFB3—Azacitidine—Gemcitabine—lung cancer	0.000192	0.0374	CbGdCrCtD
Metformin—ND1—lymph node—lung cancer	0.000176	0.00112	CbGeAlD
Metformin—SLC47A1—lung—lung cancer	0.000175	0.00112	CbGeAlD
Metformin—SLC22A3—lung—lung cancer	0.00014	0.00089	CbGeAlD
Metformin—SLC47A1—lymph node—lung cancer	0.00012	0.000764	CbGeAlD
Metformin—Muscle spasms—Docetaxel—lung cancer	0.000106	0.000662	CcSEcCtD
Metformin—Upper respiratory tract infection—Methotrexate—lung cancer	0.000106	0.000662	CcSEcCtD
Metformin—Liver function test abnormal—Doxorubicin—lung cancer	0.000105	0.000659	CcSEcCtD
Metformin—Infection—Paclitaxel—lung cancer	0.000105	0.000658	CcSEcCtD
Metformin—Dyspnoea—Cisplatin—lung cancer	0.000105	0.000658	CcSEcCtD
Metformin—Skin disorder—Etoposide—lung cancer	0.000105	0.000657	CcSEcCtD
Metformin—Hyperhidrosis—Etoposide—lung cancer	0.000104	0.000653	CcSEcCtD
Metformin—Feeling abnormal—Gemcitabine—lung cancer	0.000104	0.000652	CcSEcCtD
Metformin—Shock—Paclitaxel—lung cancer	0.000104	0.000652	CcSEcCtD
Metformin—Dizziness—Vinorelbine—lung cancer	0.000104	0.000652	CcSEcCtD
Metformin—Abdominal pain upper—Doxorubicin—lung cancer	0.000104	0.000652	CcSEcCtD
Metformin—Nervous system disorder—Paclitaxel—lung cancer	0.000104	0.00065	CcSEcCtD
Metformin—Thrombocytopenia—Paclitaxel—lung cancer	0.000104	0.000649	CcSEcCtD
Metformin—Breast disorder—Doxorubicin—lung cancer	0.000103	0.000645	CcSEcCtD
Metformin—Anorexia—Etoposide—lung cancer	0.000103	0.000644	CcSEcCtD
Metformin—Skin disorder—Paclitaxel—lung cancer	0.000103	0.000644	CcSEcCtD
Metformin—Abdominal pain—Irinotecan—lung cancer	0.000103	0.000642	CcSEcCtD
Metformin—Decreased appetite—Cisplatin—lung cancer	0.000102	0.000641	CcSEcCtD
Metformin—Hyperhidrosis—Paclitaxel—lung cancer	0.000102	0.000641	CcSEcCtD
Metformin—Nasopharyngitis—Doxorubicin—lung cancer	0.000102	0.000638	CcSEcCtD
Metformin—Gastrointestinal disorder—Cisplatin—lung cancer	0.000102	0.000637	CcSEcCtD
Metformin—Infestation NOS—Methotrexate—lung cancer	0.000101	0.000635	CcSEcCtD
Metformin—Drowsiness—Methotrexate—lung cancer	0.000101	0.000635	CcSEcCtD
Metformin—Infestation—Methotrexate—lung cancer	0.000101	0.000635	CcSEcCtD
Metformin—Anorexia—Paclitaxel—lung cancer	0.000101	0.000632	CcSEcCtD
Metformin—Hypotension—Etoposide—lung cancer	0.000101	0.000632	CcSEcCtD
Metformin—Vomiting—Vinorelbine—lung cancer	0.0001	0.000627	CcSEcCtD
Metformin—Rash—Vinorelbine—lung cancer	9.92e-05	0.000621	CcSEcCtD
Metformin—Dermatitis—Vinorelbine—lung cancer	9.91e-05	0.000621	CcSEcCtD
Metformin—Abdominal distension—Doxorubicin—lung cancer	9.91e-05	0.000621	CcSEcCtD
Metformin—Hypotension—Paclitaxel—lung cancer	9.89e-05	0.000619	CcSEcCtD
Metformin—Headache—Vinorelbine—lung cancer	9.86e-05	0.000617	CcSEcCtD
Metformin—Syncope—Docetaxel—lung cancer	9.85e-05	0.000617	CcSEcCtD
Metformin—Influenza—Doxorubicin—lung cancer	9.84e-05	0.000617	CcSEcCtD
Metformin—Palpitations—Docetaxel—lung cancer	9.71e-05	0.000608	CcSEcCtD
Metformin—Feeling abnormal—Cisplatin—lung cancer	9.71e-05	0.000608	CcSEcCtD
Metformin—Paraesthesia—Etoposide—lung cancer	9.69e-05	0.000607	CcSEcCtD
Metformin—Loss of consciousness—Docetaxel—lung cancer	9.66e-05	0.000605	CcSEcCtD
Metformin—Pancreatitis—Doxorubicin—lung cancer	9.65e-05	0.000604	CcSEcCtD
Metformin—Musculoskeletal discomfort—Paclitaxel—lung cancer	9.64e-05	0.000604	CcSEcCtD
Metformin—Dyspnoea—Etoposide—lung cancer	9.62e-05	0.000603	CcSEcCtD
Metformin—Somnolence—Etoposide—lung cancer	9.59e-05	0.000601	CcSEcCtD
Metformin—Angina pectoris—Doxorubicin—lung cancer	9.59e-05	0.000601	CcSEcCtD
Metformin—Hepatobiliary disease—Methotrexate—lung cancer	9.59e-05	0.0006	CcSEcCtD
Metformin—SLC22A3—lymph node—lung cancer	9.55e-05	0.000609	CbGeAlD
Metformin—Paraesthesia—Paclitaxel—lung cancer	9.5e-05	0.000595	CcSEcCtD
Metformin—Hypertension—Docetaxel—lung cancer	9.49e-05	0.000594	CcSEcCtD
Metformin—Dyspnoea—Paclitaxel—lung cancer	9.43e-05	0.000591	CcSEcCtD
Metformin—Somnolence—Paclitaxel—lung cancer	9.41e-05	0.000589	CcSEcCtD
Metformin—Decreased appetite—Etoposide—lung cancer	9.38e-05	0.000588	CcSEcCtD
Metformin—Chest pain—Docetaxel—lung cancer	9.36e-05	0.000586	CcSEcCtD
Metformin—Myalgia—Docetaxel—lung cancer	9.36e-05	0.000586	CcSEcCtD
Metformin—Nausea—Vinorelbine—lung cancer	9.34e-05	0.000585	CcSEcCtD
Metformin—Gastrointestinal disorder—Etoposide—lung cancer	9.32e-05	0.000584	CcSEcCtD
Metformin—Dyspepsia—Paclitaxel—lung cancer	9.31e-05	0.000583	CcSEcCtD
Metformin—Asthenia—Irinotecan—lung cancer	9.31e-05	0.000583	CcSEcCtD
Metformin—Fatigue—Etoposide—lung cancer	9.3e-05	0.000583	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	9.29e-05	0.000582	CcSEcCtD
Metformin—Constipation—Etoposide—lung cancer	9.23e-05	0.000578	CcSEcCtD
Metformin—Neutropenia—Doxorubicin—lung cancer	9.2e-05	0.000577	CcSEcCtD
Metformin—Decreased appetite—Paclitaxel—lung cancer	9.2e-05	0.000576	CcSEcCtD
Metformin—Upper respiratory tract infection—Doxorubicin—lung cancer	9.15e-05	0.000573	CcSEcCtD
Metformin—Gastrointestinal disorder—Paclitaxel—lung cancer	9.14e-05	0.000572	CcSEcCtD
Metformin—Fatigue—Paclitaxel—lung cancer	9.12e-05	0.000571	CcSEcCtD
Metformin—Hepatitis—Methotrexate—lung cancer	9.1e-05	0.00057	CcSEcCtD
Metformin—Asthenia—Gemcitabine—lung cancer	9.07e-05	0.000568	CcSEcCtD
Metformin—Constipation—Paclitaxel—lung cancer	9.05e-05	0.000567	CcSEcCtD
Metformin—Oedema—Docetaxel—lung cancer	8.97e-05	0.000562	CcSEcCtD
Metformin—Pruritus—Gemcitabine—lung cancer	8.94e-05	0.00056	CcSEcCtD
Metformin—Infection—Docetaxel—lung cancer	8.91e-05	0.000558	CcSEcCtD
Metformin—Feeling abnormal—Etoposide—lung cancer	8.89e-05	0.000557	CcSEcCtD
Metformin—Diarrhoea—Irinotecan—lung cancer	8.88e-05	0.000556	CcSEcCtD
Metformin—Gastrointestinal pain—Etoposide—lung cancer	8.82e-05	0.000553	CcSEcCtD
Metformin—Shock—Docetaxel—lung cancer	8.82e-05	0.000553	CcSEcCtD
Metformin—Nervous system disorder—Docetaxel—lung cancer	8.8e-05	0.000551	CcSEcCtD
Metformin—Thrombocytopenia—Docetaxel—lung cancer	8.78e-05	0.00055	CcSEcCtD
Metformin—Infestation NOS—Doxorubicin—lung cancer	8.78e-05	0.00055	CcSEcCtD
Metformin—Drowsiness—Doxorubicin—lung cancer	8.78e-05	0.00055	CcSEcCtD
Metformin—Infestation—Doxorubicin—lung cancer	8.78e-05	0.00055	CcSEcCtD
Metformin—Feeling abnormal—Paclitaxel—lung cancer	8.72e-05	0.000546	CcSEcCtD
Metformin—Skin disorder—Docetaxel—lung cancer	8.71e-05	0.000546	CcSEcCtD
Metformin—Gastrointestinal pain—Paclitaxel—lung cancer	8.65e-05	0.000542	CcSEcCtD
Metformin—Diarrhoea—Gemcitabine—lung cancer	8.65e-05	0.000542	CcSEcCtD
Metformin—Neuropathy peripheral—Doxorubicin—lung cancer	8.6e-05	0.000539	CcSEcCtD
Metformin—Dizziness—Irinotecan—lung cancer	8.58e-05	0.000537	CcSEcCtD
Metformin—Urticaria—Etoposide—lung cancer	8.57e-05	0.000537	CcSEcCtD
Metformin—Anorexia—Docetaxel—lung cancer	8.55e-05	0.000536	CcSEcCtD
Metformin—Abdominal pain—Etoposide—lung cancer	8.53e-05	0.000534	CcSEcCtD
Metformin—Eye disorder—Methotrexate—lung cancer	8.5e-05	0.000533	CcSEcCtD
Metformin—Asthenia—Cisplatin—lung cancer	8.45e-05	0.000529	CcSEcCtD
Metformin—Cardiac disorder—Methotrexate—lung cancer	8.44e-05	0.000529	CcSEcCtD
Metformin—Urticaria—Paclitaxel—lung cancer	8.41e-05	0.000527	CcSEcCtD
Metformin—Hypotension—Docetaxel—lung cancer	8.38e-05	0.000525	CcSEcCtD
Metformin—Abdominal pain—Paclitaxel—lung cancer	8.36e-05	0.000524	CcSEcCtD
Metformin—Hepatobiliary disease—Doxorubicin—lung cancer	8.3e-05	0.00052	CcSEcCtD
Metformin—Angiopathy—Methotrexate—lung cancer	8.26e-05	0.000517	CcSEcCtD
Metformin—Vomiting—Irinotecan—lung cancer	8.25e-05	0.000517	CcSEcCtD
Metformin—Immune system disorder—Methotrexate—lung cancer	8.22e-05	0.000515	CcSEcCtD
Metformin—Mediastinal disorder—Methotrexate—lung cancer	8.2e-05	0.000514	CcSEcCtD
Metformin—Rash—Irinotecan—lung cancer	8.18e-05	0.000512	CcSEcCtD
Metformin—Dermatitis—Irinotecan—lung cancer	8.17e-05	0.000512	CcSEcCtD
Metformin—Musculoskeletal discomfort—Docetaxel—lung cancer	8.17e-05	0.000512	CcSEcCtD
Metformin—Chills—Methotrexate—lung cancer	8.16e-05	0.000511	CcSEcCtD
Metformin—Headache—Irinotecan—lung cancer	8.13e-05	0.000509	CcSEcCtD
Metformin—Diarrhoea—Cisplatin—lung cancer	8.06e-05	0.000505	CcSEcCtD
Metformin—Paraesthesia—Docetaxel—lung cancer	8.05e-05	0.000504	CcSEcCtD
Metformin—Vomiting—Gemcitabine—lung cancer	8.04e-05	0.000503	CcSEcCtD
Metformin—Bradycardia—Doxorubicin—lung cancer	8.02e-05	0.000502	CcSEcCtD
Metformin—Dyspnoea—Docetaxel—lung cancer	8e-05	0.000501	CcSEcCtD
Metformin—Somnolence—Docetaxel—lung cancer	7.97e-05	0.000499	CcSEcCtD
Metformin—Rash—Gemcitabine—lung cancer	7.97e-05	0.000499	CcSEcCtD
Metformin—Dermatitis—Gemcitabine—lung cancer	7.96e-05	0.000499	CcSEcCtD
Metformin—Malnutrition—Methotrexate—lung cancer	7.92e-05	0.000496	CcSEcCtD
Metformin—Erythema—Methotrexate—lung cancer	7.92e-05	0.000496	CcSEcCtD
Metformin—Headache—Gemcitabine—lung cancer	7.92e-05	0.000496	CcSEcCtD
Metformin—Rhinitis—Doxorubicin—lung cancer	7.9e-05	0.000495	CcSEcCtD
Metformin—Dyspepsia—Docetaxel—lung cancer	7.89e-05	0.000495	CcSEcCtD
Metformin—Hepatitis—Doxorubicin—lung cancer	7.88e-05	0.000493	CcSEcCtD
Metformin—Hypoaesthesia—Doxorubicin—lung cancer	7.84e-05	0.000491	CcSEcCtD
Metformin—Decreased appetite—Docetaxel—lung cancer	7.8e-05	0.000488	CcSEcCtD
Metformin—Oedema peripheral—Doxorubicin—lung cancer	7.76e-05	0.000486	CcSEcCtD
Metformin—Dysgeusia—Methotrexate—lung cancer	7.76e-05	0.000486	CcSEcCtD
Metformin—Gastrointestinal disorder—Docetaxel—lung cancer	7.74e-05	0.000485	CcSEcCtD
Metformin—Asthenia—Etoposide—lung cancer	7.74e-05	0.000485	CcSEcCtD
Metformin—Connective tissue disorder—Doxorubicin—lung cancer	7.74e-05	0.000485	CcSEcCtD
Metformin—Fatigue—Docetaxel—lung cancer	7.73e-05	0.000484	CcSEcCtD
Metformin—Nausea—Irinotecan—lung cancer	7.71e-05	0.000483	CcSEcCtD
Metformin—Constipation—Docetaxel—lung cancer	7.67e-05	0.00048	CcSEcCtD
Metformin—Pruritus—Etoposide—lung cancer	7.64e-05	0.000478	CcSEcCtD
Metformin—Asthenia—Paclitaxel—lung cancer	7.59e-05	0.000476	CcSEcCtD
Metformin—Nausea—Gemcitabine—lung cancer	7.51e-05	0.00047	CcSEcCtD
Metformin—Vomiting—Cisplatin—lung cancer	7.49e-05	0.000469	CcSEcCtD
Metformin—Pruritus—Paclitaxel—lung cancer	7.49e-05	0.000469	CcSEcCtD
Metformin—Vision blurred—Methotrexate—lung cancer	7.46e-05	0.000468	CcSEcCtD
Metformin—Rash—Cisplatin—lung cancer	7.43e-05	0.000465	CcSEcCtD
Metformin—Dermatitis—Cisplatin—lung cancer	7.42e-05	0.000465	CcSEcCtD
Metformin—Feeling abnormal—Docetaxel—lung cancer	7.39e-05	0.000463	CcSEcCtD
Metformin—Diarrhoea—Etoposide—lung cancer	7.38e-05	0.000463	CcSEcCtD
Metformin—Eye disorder—Doxorubicin—lung cancer	7.36e-05	0.000461	CcSEcCtD
Metformin—Ill-defined disorder—Methotrexate—lung cancer	7.35e-05	0.00046	CcSEcCtD
Metformin—Gastrointestinal pain—Docetaxel—lung cancer	7.33e-05	0.000459	CcSEcCtD
Metformin—Cardiac disorder—Doxorubicin—lung cancer	7.31e-05	0.000458	CcSEcCtD
Metformin—Flushing—Doxorubicin—lung cancer	7.31e-05	0.000458	CcSEcCtD
Metformin—Diarrhoea—Paclitaxel—lung cancer	7.24e-05	0.000453	CcSEcCtD
Metformin—Angiopathy—Doxorubicin—lung cancer	7.15e-05	0.000448	CcSEcCtD
Metformin—Malaise—Methotrexate—lung cancer	7.14e-05	0.000447	CcSEcCtD
Metformin—Dizziness—Etoposide—lung cancer	7.14e-05	0.000447	CcSEcCtD
Metformin—Immune system disorder—Doxorubicin—lung cancer	7.12e-05	0.000446	CcSEcCtD
Metformin—Mediastinal disorder—Doxorubicin—lung cancer	7.1e-05	0.000445	CcSEcCtD
Metformin—Abdominal pain—Docetaxel—lung cancer	7.09e-05	0.000444	CcSEcCtD
Metformin—Chills—Doxorubicin—lung cancer	7.07e-05	0.000443	CcSEcCtD
Metformin—Dizziness—Paclitaxel—lung cancer	7e-05	0.000438	CcSEcCtD
Metformin—Nausea—Cisplatin—lung cancer	7e-05	0.000438	CcSEcCtD
Metformin—Vomiting—Etoposide—lung cancer	6.86e-05	0.00043	CcSEcCtD
Metformin—Malnutrition—Doxorubicin—lung cancer	6.86e-05	0.00043	CcSEcCtD
Metformin—Erythema—Doxorubicin—lung cancer	6.86e-05	0.00043	CcSEcCtD
Metformin—Rash—Etoposide—lung cancer	6.8e-05	0.000426	CcSEcCtD
Metformin—Dermatitis—Etoposide—lung cancer	6.8e-05	0.000426	CcSEcCtD
Metformin—Headache—Etoposide—lung cancer	6.76e-05	0.000423	CcSEcCtD
Metformin—Flatulence—Doxorubicin—lung cancer	6.76e-05	0.000423	CcSEcCtD
Metformin—Myalgia—Methotrexate—lung cancer	6.74e-05	0.000422	CcSEcCtD
Metformin—Chest pain—Methotrexate—lung cancer	6.74e-05	0.000422	CcSEcCtD
Metformin—Vomiting—Paclitaxel—lung cancer	6.73e-05	0.000421	CcSEcCtD
Metformin—Dysgeusia—Doxorubicin—lung cancer	6.72e-05	0.000421	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	6.7e-05	0.000419	CcSEcCtD
Metformin—Rash—Paclitaxel—lung cancer	6.67e-05	0.000418	CcSEcCtD
Metformin—Dermatitis—Paclitaxel—lung cancer	6.67e-05	0.000418	CcSEcCtD
Metformin—Discomfort—Methotrexate—lung cancer	6.66e-05	0.000417	CcSEcCtD
Metformin—Headache—Paclitaxel—lung cancer	6.63e-05	0.000415	CcSEcCtD
Metformin—Muscle spasms—Doxorubicin—lung cancer	6.59e-05	0.000413	CcSEcCtD
Metformin—Vision blurred—Doxorubicin—lung cancer	6.46e-05	0.000405	CcSEcCtD
Metformin—Asthenia—Docetaxel—lung cancer	6.43e-05	0.000403	CcSEcCtD
Metformin—Infection—Methotrexate—lung cancer	6.42e-05	0.000402	CcSEcCtD
Metformin—Nausea—Etoposide—lung cancer	6.41e-05	0.000402	CcSEcCtD
Metformin—Ill-defined disorder—Doxorubicin—lung cancer	6.36e-05	0.000399	CcSEcCtD
Metformin—Pruritus—Docetaxel—lung cancer	6.35e-05	0.000397	CcSEcCtD
Metformin—Nervous system disorder—Methotrexate—lung cancer	6.34e-05	0.000397	CcSEcCtD
Metformin—Thrombocytopenia—Methotrexate—lung cancer	6.33e-05	0.000396	CcSEcCtD
Metformin—Nausea—Paclitaxel—lung cancer	6.29e-05	0.000394	CcSEcCtD
Metformin—Skin disorder—Methotrexate—lung cancer	6.28e-05	0.000393	CcSEcCtD
Metformin—Hyperhidrosis—Methotrexate—lung cancer	6.25e-05	0.000391	CcSEcCtD
Metformin—Malaise—Doxorubicin—lung cancer	6.18e-05	0.000387	CcSEcCtD
Metformin—Anorexia—Methotrexate—lung cancer	6.16e-05	0.000386	CcSEcCtD
Metformin—Syncope—Doxorubicin—lung cancer	6.15e-05	0.000385	CcSEcCtD
Metformin—Diarrhoea—Docetaxel—lung cancer	6.14e-05	0.000384	CcSEcCtD
Metformin—Palpitations—Doxorubicin—lung cancer	6.06e-05	0.00038	CcSEcCtD
Metformin—Hypotension—Methotrexate—lung cancer	6.04e-05	0.000378	CcSEcCtD
Metformin—Loss of consciousness—Doxorubicin—lung cancer	6.03e-05	0.000378	CcSEcCtD
Metformin—Dizziness—Docetaxel—lung cancer	5.93e-05	0.000371	CcSEcCtD
Metformin—Hypertension—Doxorubicin—lung cancer	5.92e-05	0.000371	CcSEcCtD
Metformin—Musculoskeletal discomfort—Methotrexate—lung cancer	5.89e-05	0.000369	CcSEcCtD
Metformin—Chest pain—Doxorubicin—lung cancer	5.84e-05	0.000366	CcSEcCtD
Metformin—Myalgia—Doxorubicin—lung cancer	5.84e-05	0.000366	CcSEcCtD
Metformin—Paraesthesia—Methotrexate—lung cancer	5.8e-05	0.000364	CcSEcCtD
Metformin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	5.8e-05	0.000363	CcSEcCtD
Metformin—Discomfort—Doxorubicin—lung cancer	5.77e-05	0.000361	CcSEcCtD
Metformin—Dyspnoea—Methotrexate—lung cancer	5.76e-05	0.000361	CcSEcCtD
Metformin—Somnolence—Methotrexate—lung cancer	5.75e-05	0.00036	CcSEcCtD
Metformin—Vomiting—Docetaxel—lung cancer	5.7e-05	0.000357	CcSEcCtD
Metformin—Dyspepsia—Methotrexate—lung cancer	5.69e-05	0.000356	CcSEcCtD
Metformin—Rash—Docetaxel—lung cancer	5.65e-05	0.000354	CcSEcCtD
Metformin—Dermatitis—Docetaxel—lung cancer	5.65e-05	0.000354	CcSEcCtD
Metformin—Decreased appetite—Methotrexate—lung cancer	5.62e-05	0.000352	CcSEcCtD
Metformin—Headache—Docetaxel—lung cancer	5.62e-05	0.000352	CcSEcCtD
Metformin—Oedema—Doxorubicin—lung cancer	5.6e-05	0.000351	CcSEcCtD
Metformin—Gastrointestinal disorder—Methotrexate—lung cancer	5.58e-05	0.00035	CcSEcCtD
Metformin—Fatigue—Methotrexate—lung cancer	5.57e-05	0.000349	CcSEcCtD
Metformin—Infection—Doxorubicin—lung cancer	5.56e-05	0.000348	CcSEcCtD
Metformin—Shock—Doxorubicin—lung cancer	5.51e-05	0.000345	CcSEcCtD
Metformin—Nervous system disorder—Doxorubicin—lung cancer	5.49e-05	0.000344	CcSEcCtD
Metformin—Thrombocytopenia—Doxorubicin—lung cancer	5.48e-05	0.000343	CcSEcCtD
Metformin—Skin disorder—Doxorubicin—lung cancer	5.44e-05	0.000341	CcSEcCtD
Metformin—Hyperhidrosis—Doxorubicin—lung cancer	5.41e-05	0.000339	CcSEcCtD
Metformin—Anorexia—Doxorubicin—lung cancer	5.34e-05	0.000334	CcSEcCtD
Metformin—Nausea—Docetaxel—lung cancer	5.33e-05	0.000334	CcSEcCtD
Metformin—Feeling abnormal—Methotrexate—lung cancer	5.33e-05	0.000334	CcSEcCtD
Metformin—Gastrointestinal pain—Methotrexate—lung cancer	5.29e-05	0.000331	CcSEcCtD
Metformin—Hypotension—Doxorubicin—lung cancer	5.23e-05	0.000328	CcSEcCtD
Metformin—Urticaria—Methotrexate—lung cancer	5.14e-05	0.000322	CcSEcCtD
Metformin—Abdominal pain—Methotrexate—lung cancer	5.11e-05	0.00032	CcSEcCtD
Metformin—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.1e-05	0.000319	CcSEcCtD
Metformin—Paraesthesia—Doxorubicin—lung cancer	5.03e-05	0.000315	CcSEcCtD
Metformin—Dyspnoea—Doxorubicin—lung cancer	4.99e-05	0.000313	CcSEcCtD
Metformin—Somnolence—Doxorubicin—lung cancer	4.98e-05	0.000312	CcSEcCtD
Metformin—Dyspepsia—Doxorubicin—lung cancer	4.93e-05	0.000309	CcSEcCtD
Metformin—Decreased appetite—Doxorubicin—lung cancer	4.87e-05	0.000305	CcSEcCtD
Metformin—Gastrointestinal disorder—Doxorubicin—lung cancer	4.83e-05	0.000303	CcSEcCtD
Metformin—Fatigue—Doxorubicin—lung cancer	4.83e-05	0.000302	CcSEcCtD
Metformin—Constipation—Doxorubicin—lung cancer	4.79e-05	0.0003	CcSEcCtD
Metformin—Asthenia—Methotrexate—lung cancer	4.64e-05	0.000291	CcSEcCtD
Metformin—Feeling abnormal—Doxorubicin—lung cancer	4.61e-05	0.000289	CcSEcCtD
Metformin—Gastrointestinal pain—Doxorubicin—lung cancer	4.58e-05	0.000287	CcSEcCtD
Metformin—Pruritus—Methotrexate—lung cancer	4.57e-05	0.000286	CcSEcCtD
Metformin—Urticaria—Doxorubicin—lung cancer	4.45e-05	0.000279	CcSEcCtD
Metformin—Abdominal pain—Doxorubicin—lung cancer	4.42e-05	0.000277	CcSEcCtD
Metformin—Diarrhoea—Methotrexate—lung cancer	4.42e-05	0.000277	CcSEcCtD
Metformin—Dizziness—Methotrexate—lung cancer	4.27e-05	0.000268	CcSEcCtD
Metformin—Vomiting—Methotrexate—lung cancer	4.11e-05	0.000257	CcSEcCtD
Metformin—Rash—Methotrexate—lung cancer	4.08e-05	0.000255	CcSEcCtD
Metformin—Dermatitis—Methotrexate—lung cancer	4.07e-05	0.000255	CcSEcCtD
Metformin—Headache—Methotrexate—lung cancer	4.05e-05	0.000254	CcSEcCtD
Metformin—Asthenia—Doxorubicin—lung cancer	4.02e-05	0.000252	CcSEcCtD
Metformin—Pruritus—Doxorubicin—lung cancer	3.96e-05	0.000248	CcSEcCtD
Metformin—Nausea—Methotrexate—lung cancer	3.84e-05	0.000241	CcSEcCtD
Metformin—Diarrhoea—Doxorubicin—lung cancer	3.83e-05	0.00024	CcSEcCtD
Metformin—Dizziness—Doxorubicin—lung cancer	3.7e-05	0.000232	CcSEcCtD
Metformin—Vomiting—Doxorubicin—lung cancer	3.56e-05	0.000223	CcSEcCtD
Metformin—Rash—Doxorubicin—lung cancer	3.53e-05	0.000221	CcSEcCtD
Metformin—Dermatitis—Doxorubicin—lung cancer	3.53e-05	0.000221	CcSEcCtD
Metformin—Headache—Doxorubicin—lung cancer	3.51e-05	0.00022	CcSEcCtD
Metformin—Nausea—Doxorubicin—lung cancer	3.32e-05	0.000208	CcSEcCtD
Metformin—NDUFS4—Metabolism—PIK3CA—lung cancer	5.66e-06	2.72e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—PIK3CA—lung cancer	5.66e-06	2.72e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—PIK3CA—lung cancer	5.66e-06	2.72e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—PIK3CA—lung cancer	5.66e-06	2.72e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—PIK3CA—lung cancer	5.66e-06	2.72e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—PIK3CA—lung cancer	5.66e-06	2.72e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—PIK3CA—lung cancer	5.66e-06	2.72e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—PIK3CA—lung cancer	5.66e-06	2.72e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—PIK3CA—lung cancer	5.66e-06	2.72e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—PIK3CA—lung cancer	5.66e-06	2.72e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—PIK3CA—lung cancer	5.66e-06	2.72e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—PIK3CA—lung cancer	5.66e-06	2.72e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—PIK3CA—lung cancer	5.66e-06	2.72e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—PIK3CA—lung cancer	5.66e-06	2.72e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—PIK3CA—lung cancer	5.66e-06	2.72e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ERBB3—lung cancer	5.66e-06	2.72e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—POMC—lung cancer	5.63e-06	2.71e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTA3—lung cancer	5.55e-06	2.66e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—RRM1—lung cancer	5.55e-06	2.66e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—CREBBP—lung cancer	5.49e-06	2.64e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ENO1—lung cancer	5.46e-06	2.62e-05	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—CREBBP—lung cancer	5.46e-06	2.62e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—EP300—lung cancer	5.45e-06	2.62e-05	CbGpPWpGaD
Metformin—NDUFB11—Metabolism—AKT1—lung cancer	5.44e-06	2.61e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TERT—lung cancer	5.42e-06	2.6e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—MDM2—lung cancer	5.41e-06	2.6e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—RAF1—lung cancer	5.39e-06	2.59e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—AVP—lung cancer	5.29e-06	2.54e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—FGFR1—lung cancer	5.26e-06	2.53e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—B4GALT5—lung cancer	5.21e-06	2.51e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CD—lung cancer	5.2e-06	2.5e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HIF1A—lung cancer	5.18e-06	2.49e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—RRM1—lung cancer	5.17e-06	2.48e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTA3—lung cancer	5.17e-06	2.48e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—ALB—lung cancer	5.14e-06	2.47e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—ABCB1—lung cancer	5.12e-06	2.46e-05	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—ALB—lung cancer	5.11e-06	2.45e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTA4—lung cancer	5.07e-06	2.44e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—PIK3CA—lung cancer	5.05e-06	2.42e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—MDM2—lung cancer	5.04e-06	2.42e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—RAF1—lung cancer	5.02e-06	2.41e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—APOA1—lung cancer	5e-06	2.4e-05	CbGpPWpGaD
Metformin—NDUFA11—Metabolism—AKT1—lung cancer	4.97e-06	2.39e-05	CbGpPWpGaD
Metformin—NDUFB3—Metabolism—AKT1—lung cancer	4.97e-06	2.39e-05	CbGpPWpGaD
Metformin—NDUFA12—Metabolism—AKT1—lung cancer	4.97e-06	2.39e-05	CbGpPWpGaD
Metformin—NDUFA1—Metabolism—AKT1—lung cancer	4.97e-06	2.39e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KDR—lung cancer	4.96e-06	2.38e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTA2—lung cancer	4.94e-06	2.38e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—AVP—lung cancer	4.93e-06	2.37e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP2E1—lung cancer	4.9e-06	2.35e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—B4GALT5—lung cancer	4.86e-06	2.34e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—NQO1—lung cancer	4.84e-06	2.33e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—ABCB1—lung cancer	4.77e-06	2.29e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTA1—lung cancer	4.77e-06	2.29e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTA4—lung cancer	4.73e-06	2.27e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ABCC3—lung cancer	4.72e-06	2.27e-05	CbGpPWpGaD
Metformin—NDUFB1—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFS4—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFA9—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFB4—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFS1—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFA3—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—ND4L—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFB6—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—ND5—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—ND6—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFS6—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—ND2—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFB7—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFA2—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFA4—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFAB1—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFV2—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFB2—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFA5—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFS5—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFB8—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFS8—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFV1—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFA7—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFB9—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—ND4—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFA8—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—ND3—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFB5—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFA13—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFA10—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFA6—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFC1—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—NDUFB10—Metabolism—AKT1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—SLC22A3—Transmembrane transport of small molecules—RAF1—lung cancer	4.62e-06	2.22e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTA2—lung cancer	4.61e-06	2.21e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CG—lung cancer	4.57e-06	2.19e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KIT—lung cancer	4.57e-06	2.19e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—APC—lung cancer	4.57e-06	2.19e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AKR1C1—lung cancer	4.57e-06	2.19e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CB—lung cancer	4.53e-06	2.18e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EGF—lung cancer	4.51e-06	2.17e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PTGS2—lung cancer	4.49e-06	2.16e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTA1—lung cancer	4.44e-06	2.14e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—UGT1A1—lung cancer	4.43e-06	2.13e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ABCC3—lung cancer	4.39e-06	2.11e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—STK11—lung cancer	4.37e-06	2.1e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—POMC—lung cancer	4.35e-06	2.09e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—BRAF—lung cancer	4.29e-06	2.06e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—PIK3CA—lung cancer	4.29e-06	2.06e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—PIK3CA—lung cancer	4.29e-06	2.06e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—PIK3CA—lung cancer	4.29e-06	2.06e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GNG11—lung cancer	4.27e-06	2.05e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AKR1C1—lung cancer	4.26e-06	2.05e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL6R—lung cancer	4.24e-06	2.04e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CREBBP—lung cancer	4.23e-06	2.03e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—UGT1A1—lung cancer	4.13e-06	1.99e-05	CbGpPWpGaD
Metformin—NDUFV3—Metabolism—AKT1—lung cancer	4.12e-06	1.98e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ALDOA—lung cancer	4.07e-06	1.96e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—APOA1—lung cancer	4.04e-06	1.94e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MAP2K1—lung cancer	4.04e-06	1.94e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GSTP1—lung cancer	4.04e-06	1.94e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—PIK3CA—lung cancer	4.03e-06	1.94e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CD—lung cancer	4.01e-06	1.93e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GNG11—lung cancer	3.98e-06	1.91e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NCOA3—lung cancer	3.95e-06	1.9e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CAT—lung cancer	3.93e-06	1.89e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PTEN—lung cancer	3.92e-06	1.88e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmission across Chemical Synapses—HRAS—lung cancer	3.87e-06	1.86e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ABCG2—lung cancer	3.84e-06	1.85e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ADCY1—lung cancer	3.84e-06	1.85e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ABCB1—lung cancer	3.82e-06	1.84e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ALDOA—lung cancer	3.79e-06	1.82e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—HPGDS—lung cancer	3.77e-06	1.81e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ENO2—lung cancer	3.77e-06	1.81e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—APOA1—lung cancer	3.77e-06	1.81e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—TYMS—lung cancer	3.76e-06	1.8e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PPP2R1B—lung cancer	3.75e-06	1.8e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—EP300—lung cancer	3.74e-06	1.8e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—GSTM1—lung cancer	3.71e-06	1.78e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NCOA3—lung cancer	3.68e-06	1.77e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTT1—lung cancer	3.66e-06	1.76e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GCLC—lung cancer	3.61e-06	1.74e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP2A6—lung cancer	3.61e-06	1.74e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmission across Chemical Synapses—HRAS—lung cancer	3.61e-06	1.73e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MDM2—lung cancer	3.6e-06	1.73e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—RAF1—lung cancer	3.58e-06	1.72e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ADCY1—lung cancer	3.58e-06	1.72e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ABCG2—lung cancer	3.58e-06	1.72e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—ERBB2—lung cancer	3.55e-06	1.7e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CYP1A1—lung cancer	3.52e-06	1.69e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—HPGDS—lung cancer	3.51e-06	1.69e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ENO2—lung cancer	3.51e-06	1.69e-05	CbGpPWpGaD
Metformin—NDUFS7—Metabolism—AKT1—lung cancer	3.5e-06	1.68e-05	CbGpPWpGaD
Metformin—NDUFS3—Metabolism—AKT1—lung cancer	3.5e-06	1.68e-05	CbGpPWpGaD
Metformin—NDUFC2—Metabolism—AKT1—lung cancer	3.5e-06	1.68e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CB—lung cancer	3.5e-06	1.68e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MTOR—lung cancer	3.5e-06	1.68e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PPP2R1B—lung cancer	3.49e-06	1.68e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ERCC2—lung cancer	3.49e-06	1.68e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ENO1—lung cancer	3.43e-06	1.65e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—CREBBP—lung cancer	3.42e-06	1.64e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTT1—lung cancer	3.41e-06	1.64e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GCLC—lung cancer	3.37e-06	1.62e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP2A6—lung cancer	3.37e-06	1.62e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CXCL8—lung cancer	3.36e-06	1.62e-05	CbGpPWpGaD
Metformin—NDUFS2—Metabolism—AKT1—lung cancer	3.29e-06	1.58e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CASP3—lung cancer	3.22e-06	1.55e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL2—lung cancer	3.21e-06	1.54e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—ALB—lung cancer	3.2e-06	1.54e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ENO1—lung cancer	3.19e-06	1.53e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—CREBBP—lung cancer	3.19e-06	1.53e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CCND1—lung cancer	3.13e-06	1.51e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—JUN—lung cancer	3.13e-06	1.5e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP2E1—lung cancer	3.07e-06	1.48e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MMP9—lung cancer	3.04e-06	1.46e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—NQO1—lung cancer	3.04e-06	1.46e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—CDKN1A—lung cancer	3.03e-06	1.46e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PTEN—lung cancer	3.02e-06	1.45e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—APOA1—lung cancer	3.02e-06	1.45e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—ALB—lung cancer	2.99e-06	1.43e-05	CbGpPWpGaD
Metformin—SLC22A2—Neuronal System—HRAS—lung cancer	2.97e-06	1.43e-05	CbGpPWpGaD
Metformin—SLC22A2—Transmembrane transport of small molecules—RAF1—lung cancer	2.9e-06	1.39e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EP300—lung cancer	2.88e-06	1.39e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP2E1—lung cancer	2.86e-06	1.38e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—NQO1—lung cancer	2.83e-06	1.36e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—SRC—lung cancer	2.8e-06	1.35e-05	CbGpPWpGaD
Metformin—SLC22A1—Neuronal System—HRAS—lung cancer	2.77e-06	1.33e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—PIK3CA—lung cancer	2.76e-06	1.33e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CG—lung cancer	2.76e-06	1.32e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—STK11—lung cancer	2.74e-06	1.32e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—VEGFA—lung cancer	2.73e-06	1.31e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—STAT3—lung cancer	2.7e-06	1.3e-05	CbGpPWpGaD
Metformin—SLC22A1—Transmembrane transport of small molecules—RAF1—lung cancer	2.7e-06	1.3e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—NRAS—lung cancer	2.7e-06	1.3e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—POMC—lung cancer	2.62e-06	1.26e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MAPK3—lung cancer	2.58e-06	1.24e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—CREBBP—lung cancer	2.56e-06	1.23e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—STK11—lung cancer	2.55e-06	1.23e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTP1—lung cancer	2.53e-06	1.22e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—MYC—lung cancer	2.51e-06	1.21e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CAT—lung cancer	2.47e-06	1.18e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—EGFR—lung cancer	2.46e-06	1.18e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CD—lung cancer	2.42e-06	1.16e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ABCB1—lung cancer	2.4e-06	1.15e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—ALB—lung cancer	2.39e-06	1.15e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTP1—lung cancer	2.36e-06	1.13e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—TYMS—lung cancer	2.36e-06	1.13e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—GSTM1—lung cancer	2.33e-06	1.12e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—KRAS—lung cancer	2.32e-06	1.12e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CAT—lung cancer	2.3e-06	1.1e-05	CbGpPWpGaD
Metformin—ND1—Metabolism—AKT1—lung cancer	2.26e-06	1.09e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ABCB1—lung cancer	2.24e-06	1.07e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CYP1A1—lung cancer	2.21e-06	1.06e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—TYMS—lung cancer	2.2e-06	1.06e-05	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ERCC2—lung cancer	2.19e-06	1.05e-05	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—GSTM1—lung cancer	2.17e-06	1.04e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—PIK3CA—lung cancer	2.13e-06	1.03e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CB—lung cancer	2.11e-06	1.02e-05	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTGS2—lung cancer	2.09e-06	1.01e-05	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—TP53—lung cancer	2.06e-06	9.92e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CYP1A1—lung cancer	2.06e-06	9.89e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ERCC2—lung cancer	2.04e-06	9.81e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—HRAS—lung cancer	1.97e-06	9.48e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—APOA1—lung cancer	1.89e-06	9.1e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—IL6—lung cancer	1.89e-06	9.08e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PTEN—lung cancer	1.83e-06	8.77e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—APOA1—lung cancer	1.77e-06	8.48e-06	CbGpPWpGaD
Metformin—PRKAB1—Signaling Pathways—AKT1—lung cancer	1.74e-06	8.37e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—EP300—lung cancer	1.74e-06	8.37e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CG—lung cancer	1.73e-06	8.31e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—POMC—lung cancer	1.65e-06	7.91e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CG—lung cancer	1.61e-06	7.74e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—CREBBP—lung cancer	1.6e-06	7.7e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—POMC—lung cancer	1.53e-06	7.37e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CD—lung cancer	1.52e-06	7.3e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—ALB—lung cancer	1.5e-06	7.21e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—CREBBP—lung cancer	1.49e-06	7.18e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CD—lung cancer	1.42e-06	6.81e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—ALB—lung cancer	1.4e-06	6.72e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CB—lung cancer	1.33e-06	6.37e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTGS2—lung cancer	1.31e-06	6.31e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—PIK3CA—lung cancer	1.29e-06	6.19e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CB—lung cancer	1.24e-06	5.93e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTGS2—lung cancer	1.22e-06	5.88e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PTEN—lung cancer	1.14e-06	5.5e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—EP300—lung cancer	1.09e-06	5.25e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PTEN—lung cancer	1.07e-06	5.13e-06	CbGpPWpGaD
Metformin—SLC22A3—Metabolism—AKT1—lung cancer	1.05e-06	5.06e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—EP300—lung cancer	1.02e-06	4.89e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—PIK3CA—lung cancer	8.08e-07	3.88e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—PIK3CA—lung cancer	7.53e-07	3.62e-06	CbGpPWpGaD
Metformin—SLC22A2—Metabolism—AKT1—lung cancer	6.6e-07	3.17e-06	CbGpPWpGaD
Metformin—SLC22A1—Metabolism—AKT1—lung cancer	6.15e-07	2.96e-06	CbGpPWpGaD
